Short communication: Phase I clinical evaluation of a neutralizing monoclonal antibody against epidermal growth factor receptor in advanced brain tumor patients: Preliminary study

Article

Abstract: High levels of growth factors and their receptors have been demonstrated in human tumors. Gliomas an

Palabras claves:

Autores:

Figueredo R., Iznaga N., Lage Davila A., Menéndez A., Pérez R., Ramos M., Rodríguez V., Stevenson A., Tania Crombet, Torres F., Torres O., Veitía I.

Fuentes:

scopus